Researchers at the Icelandic biotechnology company DeCode Genetics Incorporated said they found a gene that can double the risk of type 2 diabetes, a disease that affects at least 171 million people ...
LONDON (Reuters) - U.S. biotechnology group Amgen Inc has agreed to buy unlisted Decode Genetics, a pioneer in hunting down genes linked to disease, for $415 million in cash to boost its drive to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback